Dr. Finn Bauer is Director for Solid Formulations R&D, recently launching two PVA-based excipients for sustained release and solubility enhancement through hot melt extrusion. He is a biochemist by education and holds a Doctoral degree from the University of Bayreuth, Germany. In 2016, in addition, Finn completed a Master of Business Administration at Ashridge Executive Education, Hult Internarial Business School, UK. With broad experience in managing product and application development projects, Finn has guided many programs in his 13-year career with Merck Life Sciences. Most recently, Finn has assumed additional responsibility for Merck’s Global Actives & Formulations Application Labs network.